Right Ventricular Dysfunction in Patients With Concomitant Tricuspid Regurgitation Undergoing Transcatheter Aortic Valve Implantation.

Aortic stenosis Right ventricular dysfunction Transcatheter aortic valve implantation Tricuspid regurgitation

Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
09 Feb 2023
Historique:
entrez: 8 2 2023
pubmed: 9 2 2023
medline: 9 2 2023
Statut: aheadofprint

Résumé

This study investigated the impact and predictive factors of concomitant significant tricuspid regurgitation (TR) and evaluated the roles of right ventricle (RV) function and the etiology of TR in the clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).Methods and Results: We assessed grading of TR severity, TR etiology, and RV function in pre- and post-TAVI transthoracic echocardiograms for 678 patients at Keio University School of Medicine. TR etiology was divided into 3 groups: primary TR, ventricular functional TR (FTR), and atrial FTR. The primary outcomes were all-cause and cardiovascular death. At baseline, moderate or greater TR was found in 55 (8%) patients and, after adjustment for comorbidities, was associated with increased all-cause death (hazard ratio [HR] 2.11; 95% confidence interval [CI] 1.19-3.77; P=0.011) and cardiovascular death (HR 2.29; 95% CI 1.06-4.99; P=0.036). RV dysfunction (RVD) also remained an independent predictor of cardiovascular death (HR 2.06; 95% CI 1.03-4.14; P=0.042). Among the TR etiology groups, patients with ventricular FTR had the lowest survival rate (P<0.001). Patients with persistent RVD after TAVI had a higher risk of cardiovascular death than those with a normal or recovered RV function (P<0.001). The etiology of TR and RV function play an important role in predicting outcomes in concomitant TR patients undergoing TAVI.

Sections du résumé

BACKGROUND BACKGROUND
This study investigated the impact and predictive factors of concomitant significant tricuspid regurgitation (TR) and evaluated the roles of right ventricle (RV) function and the etiology of TR in the clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).Methods and Results: We assessed grading of TR severity, TR etiology, and RV function in pre- and post-TAVI transthoracic echocardiograms for 678 patients at Keio University School of Medicine. TR etiology was divided into 3 groups: primary TR, ventricular functional TR (FTR), and atrial FTR. The primary outcomes were all-cause and cardiovascular death. At baseline, moderate or greater TR was found in 55 (8%) patients and, after adjustment for comorbidities, was associated with increased all-cause death (hazard ratio [HR] 2.11; 95% confidence interval [CI] 1.19-3.77; P=0.011) and cardiovascular death (HR 2.29; 95% CI 1.06-4.99; P=0.036). RV dysfunction (RVD) also remained an independent predictor of cardiovascular death (HR 2.06; 95% CI 1.03-4.14; P=0.042). Among the TR etiology groups, patients with ventricular FTR had the lowest survival rate (P<0.001). Patients with persistent RVD after TAVI had a higher risk of cardiovascular death than those with a normal or recovered RV function (P<0.001).
CONCLUSIONS CONCLUSIONS
The etiology of TR and RV function play an important role in predicting outcomes in concomitant TR patients undergoing TAVI.

Identifiants

pubmed: 36754386
doi: 10.1253/circj.CJ-22-0262
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Marjolein C de Jongh (MC)

Department of Cardiology, Keio University School of Medicine.
Department of Cardiology, Haga Teaching Hospital.

Hikaru Tsuruta (H)

Department of Cardiology, Keio University School of Medicine.

Kentaro Hayashida (K)

Department of Cardiology, Keio University School of Medicine.

Hiromu Hase (H)

Department of Cardiology, Keio University School of Medicine.

Nobuhiro Yoshijima (N)

Department of Cardiology, Keio University School of Medicine.

Tetsuya Saito (T)

Department of Cardiology, Keio University School of Medicine.

Sosuke Myojin (S)

Department of Cardiology, Keio University School of Medicine.

Yusuke Kobari (Y)

Department of Cardiology, Keio University School of Medicine.

Toshinobu Ryuzaki (T)

Department of Cardiology, Keio University School of Medicine.

Shohei Imaeda (S)

Department of Cardiology, Keio University School of Medicine.

Kohsuke Shirakawa (K)

Department of Cardiology, Keio University School of Medicine.

Marina Okada (M)

Department of Cardiology, Keio University School of Medicine.

Jin Endo (J)

Department of Cardiology, Keio University School of Medicine.

Keitaro Shinada (K)

Department of Cardiology, Keio University School of Medicine.

Yuji Itabashi (Y)

Department of Cardiology, Keio University School of Medicine.

Taku Inohara (T)

Department of Cardiology, Keio University School of Medicine.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine.

Jungo Kato (J)

Department of Anesthesiology, Keio University School of Medicine.

Tatsuo Takahashi (T)

Department of Cardiovascular Surgery, Keio University School of Medicine.

Masataka Yamazaki (M)

Department of Cardiovascular Surgery, Keio University School of Medicine.

Hideyuki Shimizu (H)

Department of Cardiovascular Surgery, Keio University School of Medicine.

Keiichi Fukuda (K)

Department of Cardiology, Keio University School of Medicine.

Classifications MeSH